Brain pacemaker shows promise for severe OCD

NCT ID NCT04967560

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether deep brain stimulation (DBS) — a device that sends electrical pulses to specific brain areas — can help people with severe obsessive-compulsive disorder (OCD) that hasn't improved with standard treatments. Participants receive a DBS implant targeting two brain regions linked to OCD. Half get real stimulation, half get sham (no stimulation) for three months, then all can receive real stimulation. The goal is to see if DBS significantly reduces OCD symptoms and improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
deep brain stimulation (DBS) device
What this could lead to
If it works, this could offer a new treatment option for people with severe OCD that hasn't responded to standard therapies.
What could go wrong
This is a relatively small, early-stage trial. The surgery carries risks like infection or bleeding, and the stimulation may cause side effects. It's not yet proven to work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSESSIVE - COMPULSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Brains Hospital of Hunan Province

    Changsha, Hunan, China

  • Changhai Hospital

    Shanghai, Shanghai Municipality, China

  • Huashan Hospital

    Shanghai, Shanghai Municipality, China

  • Shanghai Mental Health Center

    Shanghai, Shanghai Municipality, 200030, China

  • The First Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, China

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

  • West China Hospital

    Chengdu, Sichuan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.